E&S Healthcare Co., Ltd.

This is a new biomarker discovery technology, which has been developed by E&S Healthcare, through analysis of nucleic acids and proteins using the self-established Exosome Based Biomarker Screening System.
These Newly discovered biomarkers can be applied to ensue new diagnostic products of E&S and further optimized with other E&S technologies.